To achieve capital growth through investing in high growth, development stage biotechnology companies.
Find out MoreDate | Time | Trade Prc | Volume | Buy/Sell | Value | |
---|---|---|---|---|---|---|
21-Jun-24 | 16:15:54 | 648.0908 | 5,000 | Unknown* | 32.40k | O Ordinary Delayed publication |
21-Jun-24 | 16:35:09 | 648.00 | 5,388 | Sell* | 34.91k | UT Uncrossing Trade |
21-Jun-24 | 15:59:10 | 648.80 | 2,420 | Sell* | 15.70k | O Ordinary |
21-Jun-24 | 15:49:37 | 650.00 | 600 | Buy* | 3,900 | A Automatic Execution |
21-Jun-24 | 15:42:54 | 649.54 | 45 | Buy* | 292.29 | O Ordinary |
21-Jun-24 | 15:42:14 | 649.54 | 61 | Buy* | 396.22 | O Ordinary |
21-Jun-24 | 15:39:23 | 650.00 | 600 | Buy* | 3,900 | A Automatic Execution |
21-Jun-24 | 15:30:49 | 648.00 | 120 | Sell* | 777.60 | A Automatic Execution |
21-Jun-24 | 15:11:39 | 648.00 | 1 | Sell* | 6.48 | A Automatic Execution |
21-Jun-24 | 15:01:53 | 648.00 | 300 | Buy* | 1,944 | A Automatic Execution |
21-Jun-24 | 15:00:17 | 648.00 | 300 | Buy* | 1,944 | A Automatic Execution |
21-Jun-24 | 14:56:06 | 648.00 | 171 | Buy* | 1,108 | A Automatic Execution |
21-Jun-24 | 14:56:06 | 648.00 | 300 | Buy* | 1,944 | A Automatic Execution |
21-Jun-24 | 14:56:06 | 648.00 | 300 | Buy* | 1,944 | A Automatic Execution |
21-Jun-24 | 14:56:05 | 648.00 | 300 | Buy* | 1,944 | A Automatic Execution |